Neon Therapeutics Inc. (NTGN)

8.84 +0.53 (+6.378%)

IEX Real-Time Price

October 19, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 8.31

Price Open 8.47

Volume: 238,722

Avg Volume: 208,917

Market Cap: 250.2M

P/E Ratio -

52 Wk Range 6.17-16.23



NTGN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
27.33M
570,516
3.66
2.09%

2018-09-14
27.33M
413,710
8.20
1.51%

2018-08-31
27.33M
383,555
11.72
1.40%

2018-08-15
27.35M
340,389
4.52
1.24%




NTGN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-06
Q2 2018
N/A
-0.80 (2)
-7.84
-7.04

News

Natera and Neon Therapeutics team up cancer clinical trial (2018-10-18 16:31 SeekingAlpha)

Natera (NASDAQ: NTRA ) and Neon Therapeutics (NASDAQ: NTGN ) will collaborate on using Natera's Signatera (Research Use Only) circulating tumor DNA test as a biomarker to assess treatment response to Neon's personal cancer vaccine NEO-PV-01 in its NT-002 study. More news on: Natera, Neon…

 

Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine (2018-10-18 16:15 PR Newswire)

SAN CARLOS, Calif. , & CAMBRIDGE, Mass. , Oct. 18, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, and Neon Therapeutics, Inc. (NASDAQ: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeuti…

 


Statistics

Shares Outstanding: 28.3M

Top 15 Institution Percent: 30.80

Price To Sales: N/A

Price To Book: 1.69

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -50.99

Return On Equity: -54.34

Profit Margin: N/A

Price History

Beta: -0.81

50-day Moving Avg: 10.27

200-day Moving Avg: N/A

YTD Change: -41.07

5-day Change: 4.99

1-month Change: 1.38

3-month Change: -20.65

6-month Change: -41.07

1-year Change: -41.07

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Neon Therapeutics Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.neontherapeutics.com